title: [Single dose oral toxicity study of BMY-28100 in juvenile rats and dogs].
abstract: In order to investigate the single dose oral toxicity of BMY-28100 in juvenile animals, the drug was administered in single doses to 4-day-old and 14-day-old Crj: CD (SD) rats of both sexes at a dose of 2,000 mg/kg, and to 4-week-old beagle dogs of both sexes at doses of 500, 1,000 and 2,000 mg/kg by oral route. The results obtained are summarized as follows: 1. In rats, decreases of the body weight gain were observed for male and female rats treated with the drug on postnatal day 4 through 5 days and 3 days after dosing, respectively. There were no apparent drug-related toxic signs. No deaths occurred during the observation period. Enlargement of the cecum was found in a few rats of both sexes administered the drug on postnatal day 4 or 14. 2. In dogs, watery-mucous diarrhea observed at 2 to 3 hours after dosing in all dose groups was not dose-related. This finding lasted in some dogs till 4 days after dosing. An increased incidence of emesis was induced in all males at 2,000 mg/kg and all females of all dose groups except one female at 2,000 mg/kg. Body weights increased normally for all dogs, but one male at 1,000 mg/kg showed a transient decrease in food consumption. No drug-related histopathological changes were found. Based upon these results, BMY-28100 at 2,000 mg/kg induced no apparent toxic changes in the present experimental conditions. Therefore, the single dose oral toxicity of the drug in juvenile animals appeared to be very slight and generally similar to that in adults.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Preclinical Research Laboratories, Bristol-Myers Research Institute, Ltd.
authors.forename: T
authors.initials: T
authors.lastname: Kadota
authors.forename: H
authors.initials: H
authors.lastname: Kondoh
authors.forename: H
authors.initials: H
authors.lastname: Chikazawa
authors.forename: S
authors.initials: S
authors.lastname: Kawano
authors.forename: K
authors.initials: K
authors.lastname: Kuroyanagi
authors.forename: S
authors.initials: S
authors.lastname: Ohta
authors.forename: K
authors.initials: K
authors.lastname: Ishikawa
authors.forename: S
authors.initials: S
authors.lastname: Kai
authors.forename: H
authors.initials: H
authors.lastname: Kohmura
authors.forename: N
authors.initials: N
authors.lastname: Takahashi
mesh_terms: D000284:Administration, Oral; D000367:Age Factors; D000818:Animals; D001835:Body Weight / Q000187:drug effects*; D002511:Cephalosporins / Q000008:administration & dosage / Q000633:toxicity*; D003967:Diarrhea / Q000139:chemically induced; D004285:Dogs; D004435:Eating / Q000187:drug effects; D005260:Female; D006321:Heart / Q000187:drug effects*; D008297:Male; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains; D013154:Spleen / Q000187:drug effects; D013270:Stomach / Q000187:drug effects*; D014839:Vomiting / Q000139:chemically induced; D000097670:Cefprozil
chemical_list: D002511:Cephalosporins; D000097670:Cefprozil